Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Epilepsy Res. 2009 Jul;85(1):107-13. doi: 10.1016/j.eplepsyres.2009.03.002. Epub 2009 Apr 5.

Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.

Author information

  • 1IRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo C. da Casazza, Messina 98124, Italy. alacqua@unime.it



To analyse the prescribing pattern of newer and older antiepileptic drugs (AEDs) during the years 2003-2005.


From the Caserta-1 Local Health Service database, 93 general practitioners (GPs) were recruited. Among 127,389 individuals aged > or =15 years registered in the lists of these GPs, we selected patients who received at least one AED prescription during the study period. Use of newer and older AEDs was calculated as 1-year prevalence and incidence as well as defined daily dose (DDD) per 1000 inhabitants/day. Sub-analyses by gender, age and indication of use were performed.


Overall, prevalence and incidence of use remained stable for older AEDs, while it strongly increased for newer AEDs. In particular, 25% increase of incident treatments with newer AED have been reported from 2004 to 2005. The total volume of AED use remained stable during the study years, despite the proportion of newer AEDs slightly increased (from 24.6% in 2003 to 30.1% in 2005). The main indication of use was epileptic disorders for older AEDs (56% of users), and neuropathic pain for newer AEDs (69%).


Prevalence and incidence of use of newer AED strongly increased during the years 2003-2005 in a general practice of Southern Italy. Significant differences are shown in the prescribing pattern of newer and older medications: older AEDs are mainly used in the treatment of epileptic disorders, while newer compounds are preferred for conditions other than epilepsy, in particular neuropathic pain.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk